{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T18:34:48Z","timestamp":1775068488010,"version":"3.50.1"},"posted":{"date-parts":[[2026,3,30]]},"group-title":"Epidemiology","reference-count":23,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,3,30]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Cervical cancer remains a major public health challenge among women living with HIV (WLWH) in sub-Saharan Africa, where screening coverage remains suboptimal despite opportunities for integration within HIV care programs. Visual inspection with acetic acid (VIA) has been widely used as a low-cost screening approach in resource-limited settings.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This cross-sectional analysis utilized prospectively collected data from Project CN001 at the Coptic Hope Center for Infectious Diseases in Nairobi, Kenya, a CASCADE Clinical Trials Network site. WLWH aged 25-49 years receiving routine HIV care and undergoing VIA screening between March 11, 2025, and January 16, 2026, were included. Data from the REDCap and Kenya\u2019s electronic medical record system (KenyaEMR) captured sociodemographic characteristics, HIV clinical factors, VIA results, and cervical transformation zone (TZ) classification.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Among 857 WLWH screened with VIA, the median age was 40 years (interquartile ranges [IQR]: 34-45), and 77.2% reported a prior history of cervical cancer screening. VIA positivity was 7.4% (63\/857) and was higher in women with TZ1\/TZ2 than in those with TZ3. VIA positivity was also associated with higher HIV viral load, shorter time since HIV diagnosis, no cervical screening history, and younger age at screening. The proportion of women classified as TZ3 increased with age, from 39.5% among women aged 25-29 years to 67.7% among those aged 45-49 years, while the proportion classified as TZ1 decreased with increasing age.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Integrated screening at this urban U.S. President\u2019s Emergency Plan for AIDS Relief (PEPFAR) and CASCADE-supported HIV clinic demonstrates the feasibility of integrated cervical cancer screening programs for WLWH. Age-related TZ3 predominance and VIA limitations for older women highlight the need for refined screening strategies and continued electronic platform utilization for program monitoring to support cervical cancer elimination targets.<\/jats:p>\n                <\/jats:sec>","DOI":"10.64898\/2026.03.27.26349550","type":"posted-content","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T15:30:16Z","timestamp":1774884616000},"source":"Crossref","is-referenced-by-count":0,"title":["Cervical Cancer Screening with Visual Inspection with Acetic Acid (VIA) among Women Living with HIV in Nairobi, Kenya: Results and Transformation Zone"],"prefix":"10.64898","author":[{"given":"Xinyi","family":"Feng","sequence":"first","affiliation":[{"name":"Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramya","family":"Ginjupalli","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine, Atlanta, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith","family":"Lukhorito","sequence":"additional","affiliation":[{"name":"Coptic Hope Center for Infectious Diseases, Nairobi, Kenya"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Karanja","sequence":"additional","affiliation":[{"name":"Coptic Hope Center for Infectious Diseases, Nairobi, Kenya"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Mounir","sequence":"additional","affiliation":[{"name":"Coptic Hope Center for Infectious Diseases, Nairobi, Kenya"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Nderitu","sequence":"additional","affiliation":[{"name":"Coptic Hope Center for Infectious Diseases, Nairobi, Kenya"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Millicent","family":"Masinde","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Kenyatta National Hospital, Nairobi, Kenya"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sue","family":"Siminski","sequence":"additional","affiliation":[{"name":"Frontier Science Foundation, Amherst, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Mao","sequence":"additional","affiliation":[{"name":"Biostatistics and Medical Informatics, University of Wisconsin-Madison, Wisconsin, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikrant V.","family":"Sahasrabuddhe","sequence":"additional","affiliation":[{"name":"Division of Cancer Prevention, National Cancer Institute, NIH, Rockville, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nazha M.","family":"Diwan","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael H.","family":"Chung","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA"},{"name":"Emory University School of Medicine, Atlanta, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2026040110100592000_2026.03.27.26349550v1.1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660"},{"issue":"2","key":"2026040110100592000_2026.03.27.26349550v1.2","doi-asserted-by":"crossref","first-page":"e161","DOI":"10.1016\/S2214-109X(20)30459-9","article-title":"Estimates of the global burden of cervical cancer associated with HIV","volume":"9","year":"2021","journal-title":"The Lancet Global Health"},{"key":"2026040110100592000_2026.03.27.26349550v1.3","unstructured":"World Health Organization, International Agency for Research on Cancer. Prevention of cervical cancer through screening using visual inspection with acetic acid (VIA) and treatment with cryotherapy. A demonstration project in six African countries: Malawi, Madagascar, Nigeria, Uganda, the United Republic of Tanzania, and Zambia. 2012;"},{"issue":"1","key":"2026040110100592000_2026.03.27.26349550v1.4","doi-asserted-by":"crossref","first-page":"e1004143","DOI":"10.1371\/journal.pmed.1004143","article-title":"Regional and country-level trends in cervical cancer screening coverage in sub-Saharan Africa: A systematic analysis of population-based surveys (2000\u20132020)","volume":"20","year":"2023","journal-title":"PLOS Medicine"},{"key":"2026040110100592000_2026.03.27.26349550v1.5","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1186\/s12905-023-02479-w","article-title":"Uptake and barriers to cervical cancer screening among human immunodeficiency virus-positive women in Sub Saharan Africa: a systematic review and meta-analysis","volume":"23","year":"2023","journal-title":"BMC Womens Health"},{"key":"2026040110100592000_2026.03.27.26349550v1.6","doi-asserted-by":"crossref","first-page":"106295","DOI":"10.1016\/j.ypmed.2020.106295","article-title":"Reducing cervical cancer deaths in women living with HIV: PEPFAR and the Go Further partnership","volume":"144","year":"2021","journal-title":"Preventive Medicine"},{"issue":"7","key":"2026040110100592000_2026.03.27.26349550v1.7","doi-asserted-by":"crossref","first-page":"e26303","DOI":"10.1002\/jia2.26303","article-title":"Cervical cancer prevention and care in HIV clinics across sub\u25a1Saharan Africa: results of a facility\u25a1based survey","volume":"27","year":"2024","journal-title":"J Int AIDS Soc"},{"key":"2026040110100592000_2026.03.27.26349550v1.8","unstructured":"\u201cCASCADE\u201d Clinical Trials Network [Internet]. [cited 2026 Mar 26];Available from: http:\/\/prevention.cancer.gov\/research-areas\/networks-consortia-programs\/cascade"},{"key":"2026040110100592000_2026.03.27.26349550v1.9","unstructured":"Kenya Ministry of Health. National Cancer Screening and Early Diagnosis Guidelines, Second Edition, 2024 [Internet]. 2024 [cited 2026 Mar 25]. Available from: https:\/\/www.afro.who.int\/countries\/kenya\/publication\/national-cancer-screening-and-early-diagnosis-guidelines-second-edition-2024"},{"key":"2026040110100592000_2026.03.27.26349550v1.10","first-page":"e2300311","article-title":"Real-World Cervical Cancer Screening Uptake and Predictors of Visual Inspection With Acetic Acid Positivity Among Women Living With HIV in Care Programs in Western Kenya","volume":"10","year":"2024","journal-title":"JCO Glob Oncol"},{"key":"2026040110100592000_2026.03.27.26349550v1.11","first-page":"1442","article-title":"Cervical cancer programme, Kenya, 2011-2020: lessons to guide elimination as a public health problem","volume":"16","year":"2022","journal-title":"Ecancermedicalscience"},{"issue":"1","key":"2026040110100592000_2026.03.27.26349550v1.12","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1186\/s12905-025-04185-1","article-title":"Cervical cancer screening and treatment of VIA positive lesions among women living with HIV in Nairobi and Kajiado counties, Kenya: results from a targeted intervention implemented under the USAID Fahari ya Jamii project in supported HIV clinics","volume":"25","year":"2025","journal-title":"BMC Womens Health"},{"key":"2026040110100592000_2026.03.27.26349550v1.13","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70570-9"},{"issue":"1","key":"2026040110100592000_2026.03.27.26349550v1.14","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s12905-022-01680-7","article-title":"Support for lowering cervical cancer screening age to 25 for women living with HIV: retrospective cross-sectional programmatic data from Botswana","volume":"22","year":"2022","journal-title":"BMC Womens Health"},{"issue":"1","key":"2026040110100592000_2026.03.27.26349550v1.15","doi-asserted-by":"crossref","first-page":"e0262904","DOI":"10.1371\/journal.pone.0262904","article-title":"Association of HIV status and treatment characteristics with VIA screening outcomes in Malawi: A retrospective analysis","volume":"17","year":"2022","journal-title":"PLoS One"},{"key":"2026040110100592000_2026.03.27.26349550v1.16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0313868"},{"key":"2026040110100592000_2026.03.27.26349550v1.17","first-page":"20499361241284238","article-title":"Uptake of cervical cancer screening among sex workers living with HIV in Nairobi, Kenya: a cross-sectional study","volume":"11","year":"2024","journal-title":"Ther Adv Infect Dis"},{"issue":"13","key":"2026040110100592000_2026.03.27.26349550v1.18","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1111\/1471-0528.17200","article-title":"Cervical intraepithelial neoplasia in women with transformation zone type 3: cervical biopsy versus large loop excision","volume":"129","year":"2022","journal-title":"BJOG"},{"issue":"2","key":"2026040110100592000_2026.03.27.26349550v1.19","first-page":"195","article-title":"Type 3 Transformation Zone of the Cervix and Risk of Missed Lesions during Cervical Cancer Screening with Visual Methods: A Case Report from Cameroon","volume":"8","year":"2021","journal-title":"Obstetrics and Gynaecology Cases - Reviews - Reviews"},{"issue":"6","key":"2026040110100592000_2026.03.27.26349550v1.20","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1200\/JGO.2015.002469","article-title":"Cervical Abnormalities in South African Women Living With HIV With High Screening and Referral Rates","volume":"2","year":"2016","journal-title":"JGO"},{"key":"2026040110100592000_2026.03.27.26349550v1.21","unstructured":"World Health Organization. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention: use of mRNA tests for human papillomavirus (HPV). World Health Organization; 2021."},{"issue":"1","key":"2026040110100592000_2026.03.27.26349550v1.22","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1186\/s12905-025-04185-1","article-title":"Cervical cancer screening and treatment of VIA positive lesions among women living with HIV in Nairobi and Kajiado counties, Kenya: results from a targeted intervention implemented under the USAID Fahari ya Jamii project in supported HIV clinics","volume":"25","year":"2025","journal-title":"BMC Womens Health"},{"key":"2026040110100592000_2026.03.27.26349550v1.23","unstructured":"Cervical Cancer Elimination Initiative [Internet]. [cited 2026 Mar 25];Available from: https:\/\/www.who.int\/initiatives\/cervical-cancer-elimination-initiative"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.03.27.26349550","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T17:10:15Z","timestamp":1775063415000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.64898\/2026.03.27.26349550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,30]]},"references-count":23,"URL":"https:\/\/doi.org\/10.64898\/2026.03.27.26349550","relation":{},"subject":[],"published":{"date-parts":[[2026,3,30]]},"subtype":"preprint"}}